Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects
Article first published online: 26 MAR 2014
© 2014, The American College of Clinical Pharmacology
The Journal of Clinical Pharmacology
Volume 54, Issue 9, pages 968–978, September 2014
How to Cite
Lowe, S. L., Wong, C. J., Witcher, J., Gonzales, C. R., Dickinson, G. L., Bell, R. L., Rorick-Kehn, L., Weller, M., Stoltz, R. R., Royalty, J. and Tauscher-Wisniewski, S. (2014), Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects. Journal of Clinical Pharma, 54: 968–978. doi: 10.1002/jcph.286
- Issue published online: 5 AUG 2014
- Article first published online: 26 MAR 2014
- Accepted manuscript online: 12 MAR 2014 05:20AM EST
- Manuscript Accepted: 7 MAR 2014
- Manuscript Received: 1 DEC 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!